TMPRSS2 activity may mediate sex differences in COVID-19 severity

TMPRSS2 activity may mediate sex differences in COVID-19 severity

Bibliographic Details
Main Authors:	Derick Okwan-Duodu, Eun-Cheon Lim, Sungyong You, David M. Engman
Format:	Article
Language:	English
Published:	Nature Publishing Group 2021-03-01
Series:	Signal Transduction and Targeted Therapy
Online Access:	https://doi.org/10.1038/s41392-021-00513-7

Similar Items

COVID-19 in cancer patients: risk, clinical features, and management
by: Cuiwei Liu, et al.
Published: (2020-08-01)

Potential Implications of a Type 1 Interferon Gene Signature on COVID-19 Severity and Chronic Inflammation in Sickle Cell Disease
by: Emaan Madany, et al.
Published: (2021-07-01)

ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19
by: Donato Zipeto, et al.
Published: (2020-10-01)

Androgen regulation of pulmonary AR, TMPRSS2 and ACE2 with implications for sex-discordant COVID-19 outcomes
by: Mehdi Baratchian, et al.
Published: (2021-05-01)

Gastrointestinal cancers, ACE-2/TMPRSS2 expression and susceptibility to COVID-19
by: Sepehr Shafiee, et al.
Published: (2021-08-01)

Upregulation of ACE2 and TMPRSS2 by particulate matter and idiopathic pulmonary fibrosis: a potential role in severe COVID-19
by: Hsin-Hsien Li, et al.
Published: (2021-03-01)

Protective Role of a <em>TMPRSS2</em> Variant on Severe COVID-19 Outcome in Young Males and Elderly Women
by: Maria Monticelli, et al.
Published: (2021-04-01)

ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19
by: Mengzhen Dong, et al.
Published: (2020-11-01)

Association between ACE2 and TMPRSS2 nasopharyngeal expression and COVID-19 respiratory distress
by: Átila Duque Rossi, et al.
Published: (2021-05-01)

The Pursuit of COVID-19 Biomarkers: Putting the Spotlight on ACE2 and TMPRSS2 Regulatory Sequences
by: Ayelet Barash, et al.
Published: (2020-10-01)

ACE-2, TMPRSS2 and Beyond; Promising Targets and Tools for COVID-19 Prophylaxis and Treatment
by: Akçahan GEPDİREMEN, et al.
Published: (2020-12-01)

New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis
by: Yuan Hou, et al.
Published: (2020-07-01)

COVID-19 pandemic; transmembrane protease serine 2 (TMPRSS2) inhibitors as potential drugs.
by: Jerzy Jankun
Published: (2020-04-01)

Common variants at 21q22.3 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe COVID-19
by: Immacolata Andolfo, et al.
Published: (2021-04-01)

Contemplating on the Etiology of COVID-19 Severity and Mortality Sex Differences
by: Dorit Shweiki PhD
Published: (2020-10-01)

Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19
by: Qu Deng, et al.
Published: (2021-03-01)

Identification of 13 Guanidinobenzoyl- or Aminidinobenzoyl-Containing Drugs to Potentially Inhibit TMPRSS2 for COVID-19 Treatment
by: Xiaoqiang Huang, et al.
Published: (2021-06-01)

Blocking serine protease (TMPRSS2) by Bromhexine; looking at potential treatment to prevent COVID-19 infection
by: Ramin Tolouian, et al.
Published: (2020-07-01)

Spontaneous binding of potential COVID-19 drugs (Camostat and Nafamostat) to human serine protease TMPRSS2
by: Haixia Zhu, et al.
Published: (2021-01-01)

High expression of ACE2 and TMPRSS2 and clinical characteristics of COVID-19 in colorectal cancer patients
by: Chao Liu, et al.
Published: (2021-01-01)

Initial study on TMPRSS2 p.Val160Met genetic variant in COVID-19 patients
by: Laksmi Wulandari, et al.
Published: (2021-05-01)

Parallels in Sepsis and COVID-19 Conditions: Implications for Managing Severe COVID-19
by: Charles Ochieng’ Olwal, et al.
Published: (2021-02-01)

Functional analysis of zebrafish tmprss3a and tmprss3-like gene
by: Ying-Ru Lee, et al.
Published: (2016)

Age and sex differences in soluble ACE2 may give insights for COVID-19
by: Per Swärd, et al.
Published: (2020-05-01)

Routine Hematological Parameters May Be Predictors of COVID-19 Severity
by: Paulina B. Szklanna, et al.
Published: (2021-07-01)

miR-98 Regulates TMPRSS2 Expression in Human Endothelial Cells: Key Implications for COVID-19
by: Alessandro Matarese, et al.
Published: (2020-10-01)

Novel Mutations in the TMPRSS3 Gene May Contribute to Taiwanese Patients with Nonsyndromic Hearing Loss
by: Swee-Hee Wong, et al.
Published: (2020-03-01)

TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein
by: Mai Kishimoto, et al.
Published: (2021-02-01)

Sex differences in severity and mortality from COVID-19: are males more vulnerable?
by: Ajay Pradhan, et al.
Published: (2020-09-01)

Structural Variability, Expression Profile, and Pharmacogenetic Properties of TMPRSS2 Gene as a Potential Target for COVID-19 Therapy
by: Aleksei Zarubin, et al.
Published: (2021-12-01)

VACCINATION WITH MMR MAY REDUCE DISEASE SEVERITY IN COVID-19 PATIENTS
by: Johannes J. Rasker, et al.
Published: (2021-01-01)

Sputum ACE2, TMPRSS2 and FURIN gene expression in severe neutrophilic asthma
by: Nazanin Zounemat Kermani, et al.
Published: (2021-01-01)

Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial.
by: Jesper D. Gunst, et al.
Published: (2021-05-01)

Functional analysis of the TMPRSS3 gene
by: Cen-Hong, et al.
Published: (2011)

Preinfection laboratory parameters may predict COVID‐19 severity in tumor patients
by: Alexander Kiani, et al.
Published: (2021-07-01)

Biomarkers of COVID-19 severity may not serve patients with polycystic ovary syndrome
by: Abu Saleh Md Moin, et al.
Published: (2021-02-01)

Perceived susceptibility, severity, and reinfection of COVID-19 may influence vaccine acceptance
by: Sanjana Kathiravan, et al.
Published: (2021-01-01)

Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2.
by: Tianling Ou, et al.
Published: (2021-01-01)

Sex differences in COVID-19 infections
by: Spahi, Majlinda
Published: (2020)

Correction to: Sputum ACE2, TMPRSS2 and FURIN gene expression in severe neutrophilic asthma
by: Nazanin Zounemat Kermani, et al.
Published: (2021-02-01)